Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9M | $6.6M | $3.7M | $0 | $0 | $30,000 | $0 | $263 | $15,434 | $5,918 | $0 | — |
| Gross profit | $2.1M | $3.7M | $1.7M | $0 | — | $5,000 | $0 | — | — | — | — | — |
| Research & development | — | — | — | — | — | — | — | $91,852 | $87,307 | $114,044 | $31,323 | $0 |
| Operating expenses | $2.3M | $2.6M | $2.1M | $1.2M | $1.3M | $1.6M | $4.7M | $1.3M | $924,741 | $1.7M | $2.7M | $358,207 |
| Net income | −$1.4M | $160,504 | −$323,670 | −$4.5M | $272,881 | −$7.1M | −$10.4M | −$1.9M | −$1.7M | −$2.3M | −$2.7M | −$358,340 |
| Basic EPSper diluted share | -$0.00 | $0.00 | -$0.00 | -$0.01 | $0.00 | -$0.01 | -$0.03 | -$0.04 | -$0.72 | -$85.84 | -$0.34 | -$0.03 |
| Diluted EPSper diluted share | -$0.00 | $0.00 | -$0.00 | -$0.01 | $0.00 | -$0.01 | -$0.03 | -$0.04 | -$0.72 | -$85.84 | -$0.34 | -$0.03 |